Consequently, the ability to specifically regulate NK cell effector functions through inhibiting NKG2D ligand shedding by metalloproteinases or apoptosis inhibitors may present potential therapeutic benefit by preventing or alleviating pathogenesis in certain autoimmune diseases. Here, KLRK1 is linked to autoimmune disease.